Multicentre controlled open randomised clinical trial to assess efficacy and safety of an anti-tuberculosis drug combination based on optimised-dose rifampicin, optimised-dose moxifloxacin and optimised-dose linezolid for TB: the RML-TB trial protoco

Authors

Institutions

Publication Details

Journal
BMJ Open Respiratory Research
Published
2025-12-01
DOI
https://doi.org/10.1136/bmjresp-2024-002475
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Multicentre controlled open randomised clinical trial to assess efficacy and safety of an anti-tuberculosis drug combination based on optimised-dose rifampicin, optimised-dose moxifloxacin and optimised-dose linezolid for TB: the RML-TB trial protoco

Xavier Clop i García, Virginia Pomar Solchaga, Rafael Luque Márquez, Joan-Pau Millet et al.
BMJ Open Respiratory Research
Tuberculosis Research and Epidemiology
article

Multicentre controlled open randomised clinical trial to assess efficacy and safety of an anti-tuberculosis drug combination based on optimised-dose rifampicin, optimised-dose moxifloxacin and optimised-dose linezolid for TB: the RML-TB trial protoco

Xavier Clop i García, Virginia Pomar Solchaga, Rafael Luque Márquez, Joan-Pau Millet, Tamar Talaván Zanón, Verónica González Galán, María Francisca Portero, Núria Saborit, Ramón Rabuñal Rey, Jesús Troya, Raymond Serrano, Juan Espinosa Pereiro, Francisco Sanz, Marcos Díez, María Luisa Aznar, Adrián Sánchez‐Montalvá, Ana Gil-Brusola, Marta Montero, Juan Francisco Medina Gallardo, Luis Anibarro, Pilar Alonso García, Pedro Antonio García López, Joan Martínez Campreciós, Enrique Navas, Alberto Díaz de Santiago, María Teresa Tórtola Fernández, Laura Diab Casares, Montserrat Garrigó Fullola
article en

Abstract

No abstract available for this paper.
BMJ Open Respiratory ResearchVol. 12(1)
Universitat Autònoma de Barcelona (ES), Universitat de València (ES), Instituto de Salud Carlos III (ES), Hospital de Sant Pau (ES), Hospital Universitari i Politècnic La Fe (ES), Hospital Universitario Puerta de Hierro Majadahonda (ES), Sociedad Española de Medicina de Familia y Comunitaria (ES), Centre for Biomedical Network Research on Rare Diseases (ES), Hospital Clínic de Barcelona (ES), Public Health Agency (GB), Catalan Society of Family and Community Medicine (ES), Vall d'Hebron Hospital Universitari (ES), Hospital General Universitario De Valencia (ES), Instituto de Biomedicina de Sevilla (ES), Biomedical Research Institute (US), Spanish Society of Hematology and Hemotherapy (ES), Hospital Universitario Lucus Augusti (ES), Instituto de Investigación Sanitaria de Santiago (ES), Hospital Universitario Virgen del Rocío (ES), Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (ES), Complejo Hospitalario de Pontevedra (ES), Hospital Universitario Ramón y Cajal (ES), Biomedal (Spain) (ES), Hospital Universitario Infanta Leonor (ES)
Openalex Percentile: Top 55%
Tuberculosis Research and Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.